USE OF DLL4 CELL FACTOR IN PREPARING DRUG FOR TREATING FULMINANT HEPATIC FAILURE

摘要

The present invention provides a use of the DLL4 cell factor in preparing a drug for treating fulminant hepatic failure. DLL4 can not only significantly improve the survival rate in a treatment of fulminant hepatic failure, but also significantly improve the survival rate by improving prognosis of a treatment of a severe or terminal stage hepatic disease having a similar underlying cause, disease progression and prognosis.